The $3.4 Billion Lesson Pharma Faces in Shelved Drugs
Thousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
Explore effective ways to make money and pay off debt. Boost your finances and achieve your goals with our actionable tips.
28,655 articlesThousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
Two AI bets with very different risk profiles surfaced as Microsoft and Palantir reported earnings. Microsoft leans o...
AMLP offers a steady, roughly 7% yield from energy infrastructure. This article explains why most retirees overlook A...
As bond yields wobble, energy stocks secretly better provide income with inflation protection and strong cash flow. E...
Dell Technologies beat on revenue with a strong AI server push, while Super Micro Computer posted healthy growth that...
A major institutional move is shaping Balchem's next chapter. As the company posts record sales, a new investor stake...
MP Materials faced a notable price drop in June, but the reasons run deeper than a single policy move. This article b...
Two of Washington’s most watched political figures disclosed stakes in Vistra, a mid-size energy player poised as AI ...
XRP eased lower toward a critical support level as sellers held sway, signaling thinning upside momentum for the near...
In a red-hot market, the lender with the quickest, most confident decision wins the land deal. A data-driven approach...
Poet Technologies stock plummeted today as shares fell in a broad tech rotation. This deep dive explains the main dri...
KLAC stock has captured investor attention as semiconductor tool demand shifts with AI and data growth. This guide br...